KR950700068A - 치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds) - Google Patents

치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds)

Info

Publication number
KR950700068A
KR950700068A KR1019940702596A KR19940702596A KR950700068A KR 950700068 A KR950700068 A KR 950700068A KR 1019940702596 A KR1019940702596 A KR 1019940702596A KR 19940702596 A KR19940702596 A KR 19940702596A KR 950700068 A KR950700068 A KR 950700068A
Authority
KR
South Korea
Prior art keywords
compound
carbon atoms
administered
hydrate
hydrogen
Prior art date
Application number
KR1019940702596A
Other languages
English (en)
Korean (ko)
Inventor
메리 베드거 앨리슨
Original Assignee
스튜어트 알. 슈터
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스튜어트 알. 슈터, 스미스클라인 비참 코포레이션 filed Critical 스튜어트 알. 슈터
Publication of KR950700068A publication Critical patent/KR950700068A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019940702596A 1992-01-28 1993-01-27 치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds) KR950700068A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929201803A GB9201803D0 (en) 1992-01-28 1992-01-28 Methods
GB9201803.5 1992-01-28
PCT/US1993/000730 WO1993014760A2 (fr) 1992-01-28 1993-01-27 Procedes

Publications (1)

Publication Number Publication Date
KR950700068A true KR950700068A (ko) 1995-01-16

Family

ID=10709398

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702596A KR950700068A (ko) 1992-01-28 1993-01-27 치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds)

Country Status (7)

Country Link
EP (1) EP0624089A4 (fr)
JP (1) JPH07503252A (fr)
KR (1) KR950700068A (fr)
AU (1) AU666175B2 (fr)
CA (1) CA2128535A1 (fr)
GB (1) GB9201803D0 (fr)
WO (1) WO1993014760A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
US7273859B2 (en) * 2004-05-12 2007-09-25 Bristol-Myers Squibb Company HIV integrase inhibitors: cyclic pyrimidinone compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US181704A (en) * 1876-08-29 Improvement in flour-dressing machines
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
WO1992004899A1 (fr) * 1990-09-24 1992-04-02 Smithkline Beecham Corporation Methodes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors

Also Published As

Publication number Publication date
EP0624089A4 (en) 1994-12-14
WO1993014760A3 (fr) 1993-09-02
AU3595193A (en) 1993-09-01
JPH07503252A (ja) 1995-04-06
WO1993014760A2 (fr) 1993-08-05
EP0624089A1 (fr) 1994-11-17
GB9201803D0 (en) 1992-03-11
AU666175B2 (en) 1996-02-01
CA2128535A1 (fr) 1993-08-05

Similar Documents

Publication Publication Date Title
HUP0001170A2 (hu) Hatóanyagként enzimidazol-2-karbamát-származékokat tartalmazó, vírusfertőzések és rák kezelésére alkalmas gyógyszerkészítmények
KR890701562A (ko) 면역조절 아자스 피란류
TW218018B (fr)
KR950003276A (ko) 당단백질 IIb/IIIa 길항물질
EP1331005A4 (fr) Compositions medicinales destinees a etre utilise de maniere concomitante comme agent anticancereux
DE69413237D1 (en) Plättchenaggregationsinhibitoren
KR870003974A (ko) 비시클로 치환된 페닐아세토니트릴 유도체
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
KR930702975A (ko) 사이토킨 억제제
GR3025764T3 (en) Platelet aggregation inhibitors.
KR890014107A (ko) 백금 화학 요법약제
KR950700068A (ko) 치환된 아자스피란 화합물을 투여하여 사람 면역결핍 바이러스 유도된 후천성 면역결핍 증후군을 지연시키는 방법(A method for delaying HIV in-duced AIDS by administration of substituted azasperane compounds)
KR920019350A (ko) 자기면역질환요법을 위한 약제조성물
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
SE8001425L (sv) Cytostatiskt verkande lekemedel resp farmaceutiska beredningar
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR900004342A (ko) 튜마토이드 관절염 치료용 약제의 제조를 위한 6-할로-4-퀴놀론 화합물 및 이의 약제학적 조성물의 용도
KR980002033A (ko) 트리아졸 유도체 또는 그 염
CA2167841A1 (fr) Methode d'inhibition de la production de virus d'immunodeficience humaine a l'aide de derives de substitution d'azaspiranes
OA09416A (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
KR950702830A (ko) 치환된 아자스피란을 사용한 건선 치료 방법(methods of treating psoriasis employing substituted azaspiranes)
NZ233901A (en) Aminoalkyl-substituted benzophenone derivatives and analogues, pharmaceutical compositions and precursor compounds
KR970704446A (ko) 아자스피란에 의한 기회 감염의 치료 방법(Method of Treating Opportunistic lnfections with Azaspiranes)
KR970700032A (ko) 항 hiv제(anti-hiv agent)
KR930001906A (ko) 벤즈이미다졸린-2-옥소-1-카복실산 유도체의 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application